135 related articles for article (PubMed ID: 37079076)
21. Intensive sampling of the umbra and penumbra improves clinically significant prostate cancer detection and reduces risk of grade group upgrading at radical prostatectomy.
Lee AYM; Chen K; Cheng CWS; Ho HSS; Yuen JSP; Ngo NT; Law YM; Tay KJ
World J Urol; 2023 Aug; 41(8):2265-2271. PubMed ID: 37395756
[TBL] [Abstract][Full Text] [Related]
22. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
[TBL] [Abstract][Full Text] [Related]
23. Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy.
Xu G; Li JH; Xiang LH; Yang B; Chen YC; Sun YK; Zhao BH; Wu J; Sun LP; Xu HX
Asian J Androl; 2023; 25(3):410-415. PubMed ID: 36348578
[TBL] [Abstract][Full Text] [Related]
24. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
[TBL] [Abstract][Full Text] [Related]
26. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
27. Combination of fusion guided multiparametric MRI-transrectal US with systematic biopsy of the prostate for the detection of clinically significant prostate cancer: A prospective single-center study.
Agrotis G; Tsougos I; Oikonomou A; Vassiou K; Karatzas A; Tamposis I; Fanariotis M; Vamvakas A; Tzortzis V; Vlychou M
J Clin Ultrasound; 2023; 51(6):1101-1111. PubMed ID: 37267147
[TBL] [Abstract][Full Text] [Related]
28. Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?
Pepe P; Garufi A; Priolo G; Pennisi M
World J Urol; 2016 Sep; 34(9):1249-53. PubMed ID: 26699628
[TBL] [Abstract][Full Text] [Related]
29. Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?
Liu H; Ruan M; Wang H; Wang H; Li X; Song G
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):589-595. PubMed ID: 32719353
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsies increase the rate of cancer detection in populations with a low incidence of prostate cancer.
Kaushal R; Das CJ; Singh P; Dogra PN; Kumar R
Investig Clin Urol; 2019 May; 60(3):156-161. PubMed ID: 31098422
[TBL] [Abstract][Full Text] [Related]
31. Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy.
Hansen NL; Barrett T; Lloyd T; Warren A; Samel C; Bratt O; Kastner C
BJU Int; 2020 Feb; 125(2):260-269. PubMed ID: 31306539
[TBL] [Abstract][Full Text] [Related]
32. Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation.
Galosi AB; Maselli G; Sbrollini G; Donatelli G; Montesi L; Tallè M; Montironi R
Arch Ital Urol Androl; 2016 Dec; 88(4):292-295. PubMed ID: 28073195
[TBL] [Abstract][Full Text] [Related]
33. MRI ultrasound fusion biopsy in prostate cancer detection: Are randomized clinical trials reproducible in everyday clinical practice?
Cattarino S; Forte V; Salciccia S; Drudi FM; Cantisani V; Sciarra A; Fasulo A; Ciccariello M
Urologia; 2019 Feb; 86(1):9-16. PubMed ID: 30890102
[TBL] [Abstract][Full Text] [Related]
34. Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy.
Mischinger J; Kaufmann S; Russo GI; Harland N; Rausch S; Amend B; Scharpf M; Loewe L; Todenhoefer T; Notohamiprodjo M; Nikolaou K; Stenzl A; Bedke J; Kruck S
BJU Int; 2018 May; 121(5):791-798. PubMed ID: 29211932
[TBL] [Abstract][Full Text] [Related]
35. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection.
Petov V; Bazarkin A; Morozov A; Taratkin M; Ganzha T; Danilov S; Chernov Y; Chinenov D; Rzayev R; Suvorov A; Amosov A; Fajkovic H; Enikeev D; Krupinov G
J Endourol; 2023 Aug; 37(8):940-947. PubMed ID: 37294206
[No Abstract] [Full Text] [Related]
36. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Real-Time Virtual Sonography Navigation Versus BioJet Navigation on Magnetic Resonance Imaging-Guided Prostate Needle Biopsy: A Single Institutional Analysis.
Nagai T; Naiki T; Hamamoto S; Etani T; Naiki-Ito A; Nakagawa M; Iida K; Iwatsuki S; Taguchi K; Maruyama T; Kawai N; Takahashi S; Yasui T
J Endourol; 2020 Jul; 34(7):739-745. PubMed ID: 32316763
[No Abstract] [Full Text] [Related]
38. Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy.
Klingebiel M; Arsov C; Ullrich T; Quentin M; Al-Monajjed R; Mally D; Sawicki LM; Hiester A; Esposito I; Albers P; Antoch G; Schimmöller L
Eur J Radiol; 2021 Apr; 137():109587. PubMed ID: 33592552
[TBL] [Abstract][Full Text] [Related]
39. Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
Rakauskas A; Peters M; Martel P; van Rossum PSN; La Rosa S; Meuwly JY; Roth B; Valerio M
PLoS One; 2023; 18(1):e0280262. PubMed ID: 36652429
[TBL] [Abstract][Full Text] [Related]
40. Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy.
Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Tian Z; Karakiewicz PI; Tilki D; Fisch M; Maurer T; Graefen M; Budäus L
J Urol; 2020 Feb; 203(2):299-303. PubMed ID: 31483694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
